New drug combo tested for advanced breast cancer in japan
NCT ID NCT07164976
Summary
This trial is testing whether combining two existing drugs—ribociclib and anastrozole—works better together for people with advanced or returning breast cancer. The study will involve 86 Japanese patients whose cancer is hormone-sensitive but HER2-negative. Researchers will first check if the combination is safe, then measure how well it shrinks tumors and controls cancer growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.